A key concept of the program project is that periventricular leukomalacia (PVL) results from ischemia/reperfusion that triggers free radical injury to vulnerable developing oligodendrocytes in perinatal white matter: as a result, developing oligodendrocytes die, in part by apoptosis, thus resulting in decreased mature oligodendrocytes and impaired myelination. The overall hypothesis of the proposed study is two-fold: 1) there is a specific vulnerability of developing oligodendrocytes to oxidative stress in the cerebral white matter in the period of greatest risk for PVL (24-32 weeks) which relates, at least in part, to a mismatch between the development of the expression of antioxidant enzymes and the development of pro-oxidant pathways, such as the acquisition of iron necessary for oligodendrocyte differentiation; and 2) oxidative stress plays a major role in the pathogenesis of PVL. In baseline studies, we will determine the temporospatial maturation of oligodendrocytes in human cerebral white matter using immunocytochemical methods and markers to stage-specific oligodendrocytes. We will also determine the developmental profile of selected antioxidant enzymes and markers of pro-oxidant pathways (i.e., iron, nitric oxide synthase localization, and 12-lipoxygenase expression) in human cerebral white matter using histochemistry, immunocytochemistry, and immunoblotting. Here we will test the hypothesis that antioxidant enzymes are expressed at low levels in immature white matter during the period of greatest risk for PVL, and that the appearance of markers of pro-oxidant pathways precede the expression of antioxidant enzymes, thus denoting a developmental mismatch between potential sources of free radicals and the systems to clear them. In PVL itself, we will determine the densities of developing oligodendrocytes, indicative of a targeted death and loss of these cells. We will also determine if markers of oxidative stress are expressed in PVL. Finally, we will determine the involvement of selected cytokines in PVL. The proposed studies should provide important insight into the roles of developing oligodendrocytes and factors related to oxidative stress in PVL directly within the human brain.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
1P01NS038475-01A1
Application #
6330936
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
1999-12-10
Project End
2004-11-30
Budget Start
Budget End
Support Year
1
Fiscal Year
2000
Total Cost
$196,099
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Jantzie, Lauren L; Talos, Delia M; Jackson, Michele C et al. (2015) Developmental expression of N-methyl-D-aspartate (NMDA) receptor subunits in human white and gray matter: potential mechanism of increased vulnerability in the immature brain. Cereb Cortex 25:482-95
Elitt, C M; Rosenberg, P A (2014) The challenge of understanding cerebral white matter injury in the premature infant. Neuroscience 276:216-38
Xu, Gang; Takahashi, Emi; Folkerth, Rebecca D et al. (2014) Radial coherence of diffusion tractography in the cerebral white matter of the human fetus: neuroanatomic insights. Cereb Cortex 24:579-92
Haynes, Robin L; van Leyen, Klaus (2013) 12/15-lipoxygenase expression is increased in oligodendrocytes and microglia of periventricular leukomalacia. Dev Neurosci 35:140-54
Lippman-Bell, Jocelyn J; Rakhade, Sanjay N; Klein, Peter M et al. (2013) AMPA receptor antagonist NBQX attenuates later-life epileptic seizures and autistic-like social deficits following neonatal seizures. Epilepsia 54:1922-32
Haynes, Robin L; Sleeper, Lynn A; Volpe, Joseph J et al. (2013) Neuropathologic studies of the encephalopathy of prematurity in the late preterm infant. Clin Perinatol 40:707-22
Selip, D B; Jantzie, L L; Chang, M et al. (2012) Regional differences in susceptibility to hypoxic-ischemic injury in the preterm brain: exploring the spectrum from white matter loss to selective grey matter injury in a rat model. Neurol Res Int 2012:725184
Kinney, Hannah C; Haynes, Robin L; Xu, Gang et al. (2012) Neuron deficit in the white matter and subplate in periventricular leukomalacia. Ann Neurol 71:397-406
Manning, Simon M; Boll, Griffin; Fitzgerald, Erin et al. (2011) The clinically available NMDA receptor antagonist, memantine, exhibits relative safety in the developing rat brain. Int J Dev Neurosci 29:767-73
Volpe, Joseph J; Kinney, Hannah C; Jensen, Frances E et al. (2011) The developing oligodendrocyte: key cellular target in brain injury in the premature infant. Int J Dev Neurosci 29:423-40

Showing the most recent 10 out of 102 publications